Annotation Detail for KATNA1

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| 200114 | Lissencephaly gene (LIS1) in neuronal migration and development |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of KATNA1 mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of KATNA1 mRNA | increases expression | 20406850
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of KATNA1 mRNA | affects expression | 21346803
|
| C006780 |
bisphenol A |
bisphenol A results in decreased expression of KATNA1 mRNA | decreases expression | 20678512
|
| D008713 |
Methimazole |
Methimazole results in decreased expression of KATNA1 mRNA | decreases expression | 17403546
|
| C494474 |
perchlorate |
perchlorate results in decreased expression of KATNA1 mRNA | decreases expression | 17403546
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of KATNA1 mRNA | increases expression | 19363144
|
| D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of KATNA1 mRNA | decreases expression | 17403546
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
3.83 | 6195326 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.37 | 17620307 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
4.55 | 19483382 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.14 | 11985600 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.44 | 17123778 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.78 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.78 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.78 | 17173139 20935162 20007298 6705139 1701930 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.38 | 17123778 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.95 | 6135515 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.61 | 4080065 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.12 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.12 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.08 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.08 | 18551238 21346803 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.31 | 1851702 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.47 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.31 | 3922381 11558140 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.01 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.79 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.61 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.41 | 3659116 |
| MESH:D006042 |
Goiter |
|
perchlorate |
5.61 | 18801409 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
3.84 | 16109766 |
| MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.95 | 14678291 |
| MESH:D007037 |
Hypothyroidism |
|
Methimazole |
13.18 | 18031379 |
| MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
13.18 | 18031379 8137927 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.46 | 16393666 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.15 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.15 | 16705839 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.03 | 21047994 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.22 | 19363144 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.88 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
4.88 | 19482888 19812893 8742319 21047994 19073162 15975961 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.49 | 2876786 2876784 6135515 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
6.49 | 1399818 2563599 17172636 6150874 18308698 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.87 | 17484760 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.70 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.70 | 18551238 7678174 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.30 | 11399458 16427766 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.78 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.78 | 16049721 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.76 | 17016548 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.38 | 11985600 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.57 | 16965848 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.87 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.35 | 10548101 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.49 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.36 | 16740699 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.94 | 12752131 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.18 | 10548101 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.89 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.89 | 18551238 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
10.89 | 3137016 4039156 16876388 11442880 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.22 | 6407741 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.38 | 16684133 16045194 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
8.15 | 1399818 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
8.15 | 15710170 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.32 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.32 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.35 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.35 | 10091137 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.45 | 14652134 |